prevalence

  1. Simon M

    How much can we trust a medical diagnosis of ME/CFS? (Analysis of Newton, 2010; Devasahayam, 2012; Collin, 2012; plus more)

    Intro and summary If all we know is that someone has a medical ME/CFS diagnosis, what is the chance they do have this, or at least do not have an undetected alternative diagnosis that would explain the illness? This is particularly valuable information for biobanks, the main source of large...
  2. Chandelier

    Post-COVID symptoms prevalence, latent class pattern, and functional impact: A population-based cross-sectional study in 2 Chilean,2024, 2026, Rubilar

    Post-COVID symptoms prevalence, latent class pattern, and functional impact: A population-based cross-sectional study in two Chilean cities, 2024 Prevalencia de síntomas post-COVID, agrupamiento sintomático e impacto funcional: Estudio transversal de base poblacional en dos ciudades chilenas...
  3. Chandelier

    Review Somatoform Disorders and Medically Unexplained Symptoms in Primary Care, 2015, Haller et al.

    Somatoform Disorders and Medically Unexplained Symptoms in Primary Care Abstract Background: The literature contains variable figures on the prevalence of somatoform disorders and medically unexplained symptoms in primary care. Methods: The pertinent literature up to July 2014 was retrieved...
  4. SNT Gatchaman

    Preprint Prevalence and Functional Outcomes of Post-Exertional Malaise among Adults with prior COVID-19…, 2026, Packard et al.

    Prevalence and Functional Outcomes of Post-Exertional Malaise among Adults with prior COVID-19: Results from a Representative Survey of New York City Residents Samuel E Packard; Therese Russo; Jannae Parrott; Julia Sisti; Amanda Lans OBJECTIVE To estimate the prevalence of Post-Exertional...
  5. forestglip

    Prevalence of severe fatigue after SARS-CoV-2 infection in Norway: a prospective 2-year follow-up study, 2026, Berg et al

    Prevalence of severe fatigue after SARS-CoV-2 infection in Norway: a prospective 2-year follow-up study Objectives This study aims to estimate the prevalence of long-lasting severe fatigue and identify possible risk factors in a 2-year follow-up of patients with predominantly mild-to-moderate...
  6. forestglip

    Long-Term Health Effects of COVID-19 in Tunisia, 2020–2021, 2025, Dhaouadi et al

    Long-Term Health Effects of COVID-19 in Tunisia, 2020–2021 Background Some patients suffer from persistent symptoms following a COVID-19 infection, referred to as long COVID. The aims of the study were to estimate the prevalence of long COVID and study its determinants in Tunisia. Methods...
  7. forestglip

    Review Long COVID Prevalence and Risk Factors: A Systematic Review and Meta-Analysis of Prospective Cohort Studies, 2025, Halas et al

    Long COVID Prevalence and Risk Factors: A Systematic Review and Meta-Analysis of Prospective Cohort Studies [Line breaks added] Background: Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), affects millions globally, with persistent symptoms impacting quality of life. This...
  8. Wyva

    Variability in Long COVID Definitions and Validation of Published Prevalence Rates, 2025, Wisk et al

    Key Points Question What is the prevalence of long COVID in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE) cohort based on definitions in published literature? Findings In this prospective cohort study of 4575 INSPIRE participants, when replicating long...
  9. Sly Saint

    UK Article June 2025: Doctors said I had ‘medically unexplained symptoms’. I have to treat myself

    https://www.msn.com/en-gb/health/other/doctors-said-i-had-medically-unexplained-symptoms-i-have-to-treat-myself/ss-AA1GFvrS?ocid=msedgntp&pc=U531&cvid=2b08eeec43d847f4d05abc99e80dd6f7&ei=115#image=1
  10. forestglip

    Review Long-term neurological and cognitive impact of COVID-19: a systematic review and meta-analysis in over 4 million patients, 2025, Elboraay et al

    Long-term neurological and cognitive impact of COVID-19: a systematic review and meta-analysis in over 4 million patients Toka Elboraay, Mahmoud A. Ebada, Maged Elsayed, Heba Ahmed Aboeldahab, Hazem Mohamed Salamah, Omar Rageh, Mohamed Elmallahy, Hadeer Elsaeed AboElfarh, Lena Said Mansour...
  11. forestglip

    Estimating Long COVID-19 prevalence across definitions and forms of sample selection, 2025, Lovaglio et al

    Estimating Long COVID-19 prevalence across definitions and forms of sample selection Pietro Giorgio Lovaglio, Fabio Borgonovo, Alessandro Manzo Margiotta, Mohamed Mowafy, Marta Colaneri, Alessandra Bandera, Andrea Gori, Amedeo Ferdinando Capetti [Line breaks added] Abstract Long COVID (LC) is...
  12. forestglip

    Symptom Burden and Post-COVID-19 Syndrome 24 Months Following SARS-CoV-2 Infection: Longitudinal Population-Based Study, 2025, Peter et al

    Symptom Burden and Post-COVID-19 Syndrome 24 Months Following SARS-CoV-2 Infection: Longitudinal Population-Based Study Raphael S. Peter, Lisamaria Eble, Alexandra Nieters, Stefan O. Brockmann, Siri Göpel, Uta Merle, Jürgen M. Steinacker, Hans-Georg Kräusslich, Dietrich Rothenbacher, Winfried...
  13. forestglip

    Global prevalence of long COVID and its most common symptoms among healthcare workers: a systematic review and meta-analysis, 2025, Al-Oraibi et al

    Global prevalence of long COVID and its most common symptoms among healthcare workers: a systematic review and meta-analysis Amani Al-Oraibi, Katherine Woolf, Jatin Naidu, Laura B Nellums, Daniel Pan, Shirley Sze, Carolyn Tarrant, Christopher A Martin, Mayuri Gogoi, Joshua Nazareth, Pip Divall...
  14. H

    Exploring Long Covid Prevalence and Patient Uncertainty by Sociodemographic Characteristics Using GP Patient Survey Data, 2025, Woodrow, Alwan et al

    Link to paper https://onlinelibrary.wiley.com/doi/10.1111/hex.70202 ********** One in ten people in UK may suffer from long Covid A study highlights the continuing impact of the pandemic and raises concerns about undiagnosed cases LINK
  15. forestglip

    Review Evidence synthesis – Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence, 2025, Taher et al

    Evidence synthesis – Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence Mohamed Kadry Taher, Talia Salzman, Allyson Banal, Kate Morissette, Francesca R. Domingo, Angela M. Cheung, Curtis L. Cooper, Laura Boland, Alexandra M. Zuckermann...
  16. forestglip

    Age differences in prevalence and symptoms of post-COVID-19 condition among children: a prospective cohort study, 2025, Wu et al

    Age differences in prevalence and symptoms of post-COVID-19 condition among children: a prospective cohort study Yixin Wu, Xiangrong Sun, Jingyun Yang, Hailin Fan, Ouxuan Jin, Liwei Tang, Meixian Zhang, Lizhen Wang [Line breaks added] Abstract Some individuals experience unexplained...
  17. forestglip

    Review A systematic review of post COVID-19 condition in children and adolescents [...], 2025, Putri et al

    A systematic review of post COVID-19 condition in children and adolescents: Gap in evidence from low-and -middle-income countries and the impact of SARS-COV-2 variants Nina Dwi Putri, Ida Safitri Laksanawati, Dominicus Husada, Nastiti Kaswandani, Ari Prayitno, Rina Triasih, Irma Sri Hidayati...
  18. forestglip

    The prevalence of hypermobile Ehlers–Danlos syndrome at a gender-affirming primary care clinic, 2025, Stein et al

    The prevalence of hypermobile Ehlers–Danlos syndrome at a gender-affirming primary care clinic Theo Stein, Shannon Collins, Joshua St. Louis Objective This study utilized a sample of trangender, nonbinary, and gender-diverse (TGD) patients to build on emerging literature that suggests that...
  19. forestglip

    Long COVID has variable incidence and clinical presentations: our 6-country collaborative study, 2025, Szabo et al

    Long COVID has variable incidence and clinical presentations: our 6-country collaborative study Sandor Szabo, Iryna Muzyka, Veronika Muller, Attila J. Szabo, Attila Szijártó, Klara Gyires, Tamas Doczi, Jozsef Janszky, Andreas Stengel, Siri Göpel, Antonia Trichopoulou, Rafael Diaz, Nicte...
  20. SNT Gatchaman

    Prevalence of Post–COVID-19 Condition and Activity-Limiting Post–COVID-19 Condition Among Adults, 2024, Vahratian, Unger+

    Prevalence of Post–COVID-19 Condition and Activity-Limiting Post–COVID-19 Condition Among Adults Anjel Vahratian; Sharon Saydah; Jeanne Bertolli; Elizabeth R. Unger; Cria O. Gregory From Results — Link | PDF (JAMA Network Open) [Open Access]
Back
Top Bottom